Analyst upgrades 4-24-07: CAH, HAL, SNDK and TXN upgraded today
Posted Apr 24th 2007 11:21AM by Kevin Shult
Filed under: Before the Bell, Analyst Upgrades and Downgrades, Good news, Halliburton (HAL), Texas Instruments (TXN), Cardinal Health (CAH), SanDisk Corp (SNDK)
MOST NOTEWORTHY: GlaxoSmithKline plc (NYSE: GSK), Express Scripts, Inc (ESRX), SanDisk Corp (SNDK), Halliburton Co (HAL) and Texas Instruments (TXN) were some of today's noteworthy upgrades.
- Express Scripts Inc (NASDAQ: ESRX) was upgraded to Strong Buy from Buy with a $113 target at First Albany, following the stronger-than-expected first quarter results.
- Halliburton Co (NASDAQ: HAL) was added to AG Edwards Focus Portfolio. The firm believes Halliburton trades at a great discount to its largest peer, Schlumberger Ltd (SLB), despite an improved earnings outlook and progress on several issues.
- Texas Instruments (NASDAQ: TXN) was upgraded to Buy from Hold at Gabelli to reflect strong first quarter results and valuation. Piper Jaffray upgraded shares of Texas Instruments to Outperform from Market Perform...
OTHER UPGRADES:
- Keefe Bruyette upgraded shares of BancFirst Corp (NASDAQ: BANF) to Market Perform from Underperform following its first quarter report.
- Matrix USA raised H.B. Fuller Co (NYSE: FUL) to Hold from Sell based on the company's sales growth.
- Baird raised Snap-on Inc (NYSE: SNA) rating to Outperform from Neutral with a $55 target.
- Bear Stearns upgraded shares of Cummins Inc (NYSE: CMI) to Peer Perform from Underperform.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required). Tags: analyst, bancfirst, banf, cah, cardinal health, CardinalHealth, esrx, express scripts, ExpressScripts, fuller, glaxosmithckline, gsk, hal, halliburton, hul, rating, sandisk, sna, snap-on inc, Snap-onInc, sndk, texas instruments, TexasInstruments, theflyonthewall.com, txn, upgrade
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
